I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Cisplatin or Doxorubicin Reduces Cell Viability via the PTP..:
Li CJ
;
Tsai HW
;
Chen YL
...
https://www.dovepress.com/cisplatin-or-doxorubicin-reduces-cell-viability-via-the-ptpiva3-jak2-s-peer-reviewed-fulltext-article-JHC. , 2023
Link:
https://doaj.org/article/9cbd6dfb0b014255be3e4628d5bb8..
RT Journal T1 <Title>Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:9cbd6dfb0b014255be3e4628d5bb8967&Exemplar=1&LAN=DE A1 Li CJ A1 Tsai HW A1 Chen YL A1 Wang CI A1 Lin YH A1 Chu PM A1 Chi HC A1 Huang YC A1 Chen CY PB Dove Medical Press YR 2023 K1 hepatocellular carcinoma K1 chemoresistance K1 cisplatin K1 doxorubicin K1 ptp4a3 K1 il-6 K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.dovepress.com/cisplatin-or-doxorubicin-reduces-cell-viability-via-the-ptpiva3-jak2-s-peer-reviewed-fulltext-article-JHC LK http://dx.doi.org/https://doaj.org/article/9cbd6dfb0b014255be3e4628d5bb8967 DO https://doaj.org/article/9cbd6dfb0b014255be3e4628d5bb8967 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
